CEA antibody (F7F5)
- Mouse monoclonal antibody against CEACAM5
- Monoclonal antibody
- Mouse/Human available
Carcinoembryonic antigen (CEA) is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as atumor marker in clinical tests. CEA are glycosyl phosphatidyl inositol (GPI) cell surface anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma ligands, which may be critical to the metastatic dissemination of colon carcinoma cells.
- K.W. Huang, S.Y. Yang, H.E. Horng, J.J. Chieh, H.H. Chen, C.C. Wu, J.H. Chen, I.T. Lin, C.C. Yang, and H.C. Yang, “Time-evolution contrast of target MRI using high-stability antibody functionalized magnetic nanoparticles: An animal model”, J. Nanomater 2014, 351848.
- C.C. Yang, S.Y. Yang, C.S. Ho, J.F. Chang, B.H. Liu, and K.W. Huang, “Development of antibody functionalized magnetic nanoparticles for immunoassay ofcarcinoembryonic antigen: Feasibility study for clinic use”, J. Nanobiotech 2014, 12:44.
|Catalog Number||Description||Package Size|
|AT-CEA-F7F5-100||Mouse monoclonal antibody against CEACAM||Liquid (1.0 mg/ml × 100μl)|
- Applications Content:Western blotting: 1/10000 (HT29)
- Applications Content:ELISA: 1/200000